Exchange: NASDAQ Sector: Consumer Defensive Industry: Farm Products
7.65% $1.830
America/New_York / 23 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 7.06 mill |
EPS: | -7.17 |
P/E: | -0.260 |
Earnings Date: | May 02, 2024 |
SharesOutstanding: | 3.86 mill |
Avg Daily Volume: | 0.0252 mill |
RATING 2024-04-23 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Sell | |
P/E: | Sell | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.260 | sector: PE 9.79 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.260 | industry: PE 69.77 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 1.700 - 1.960 ( +/- 7.10%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-14 | Melbourne David Francis Jr | Sell | 0 | Common Stock |
2020-06-17 | Melbourne David Francis Jr | Sell | 15 000 | Options to Purchase Common Stock |
2021-01-02 | Melbourne David Francis Jr | Sell | 15 000 | Options to Purchase Common Stock |
2023-03-12 | Melbourne David Francis Jr | Sell | 12 799 | Options to Purchase Common Stock |
2024-03-10 | Melbourne David Francis Jr | Sell | 5 163 | Options to Purchase Common Stock |
INSIDER POWER |
---|
91.12 |
Last 98 transactions |
Buy: 1 655 566 | Sell: 12 955 296 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $1.830 (7.65% ) |
Volume | 0.0071 mill |
Avg. Vol. | 0.0252 mill |
% of Avg. Vol | 28.37 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.